EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer

Erin L. Milliken, Xiaoxue Zhang, Chris A. Flask, Jeffrey L. Duerk, Paul N. MacDonald, Ruth A. Keri

Cancer Letters · 2005 · 30 citations · 40 references

DOIFull text

Open access

Concepts

References

40